+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06607302

Prospective Observational Study of Ivosidenib Treatment in Adults with Locally Advanced or Metastatic Cholangiocarcinoma Having IDH1 R132 Mutation After Prior Systemic Therapy in Germany

Led by iOMEDICO AG · Updated on 2026-10-22

100

Participants Needed

19

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Cholangiocarcinoma is a rare and aggressive bile duct tumor with limited treatment options and a poor prognosis. Researchers are collecting real-world data on the use of the targeted drug ivosidenib in adults with locally advanced or metastatic cholangiocarcinoma who have an IDH1 R132 mutation and have already received at least one prior systemic therapy. This prospective, multicenter observational study in Germany aims to provide evidence on the effectiveness, quality of life, and safety of ivosidenib in a broad patient population. Ivosidenib will be given following the current summary of product characteristics SmPC. The study will observe patients treated with ivosidenib in routine clinical practice without altering their treatment. Data will be gathered over a maximum period of 38 months from first patient inclusion to last patient last visit, covering treatment duration and patient outcomes during this time. Participants will be monitored regularly to assess progression-free survival as the primary outcome, along with overall survival, response rates, adverse events, and quality of life measures related to cholangiocarcinoma. The study also collects information on dose modifications, treatment duration, previous therapies, concomitant medications, and physician treatment decisions. This observational study continues until December 2027, allowing long-term follow-up of patients receiving ivosidenib.

CONDITIONS

Brief Title

Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study

Research Team

S

Sina Grebhardt, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here